Report Detail

Medical Devices & Consumables (Post-pandemic Era)-Global Intravenous (IV) Solutions Market Segment Research Report 2022

  • RnM4476512
  • |
  • 04 August, 2022
  • |
  • Global
  • |
  • 107 Pages
  • |
  • XYZResearch
  • |
  • Medical Devices & Consumables

Summary

The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.

2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.

According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.

Beijing Yanjing Bizhi Information Consulting Co., Ltd. (XYZResearch)released the 《(Post-pandemic Era)-Global Intravenous (IV) Solutions Market Segment Research Report 2022》, which aims to sort out the development status and trends of the Intravenous (IV) Solutions industry at home and abroad, estimate the overall market scale of the Intravenous (IV) Solutions industry and the market share of major countries, Intravenous (IV) Solutions industry, and study and judge the downstream market demand of Intravenous (IV) Solutions through systematic research, Analyze the competition pattern of Intravenous (IV) Solutions, so as to help solve the pain points of various stakeholders in Intravenous (IV) Solutions industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.

Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Intravenous (IV) Solutions Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Intravenous (IV) Solutions Market?
ICU Medical Inc. (U.S.)
B. Braun Melsungen AG (Germany)
Fresenius Kabi AG (Germany)
Baxter (U.S.)
Amanta Healthcare (India)
Terumo Medical Corporation (Tokyo)
Grifols S.A. (Spain)
Major Type of Intravenous (IV) Solutions Covered in XYZResearch report:
Peripheral Parenteral Nutrition
Total Parenteral Nutrition
Application Segments Covered in XYZResearch Market
Hospital & Clinics
Ambulatory
Home Care

For any other requirements, please feel free to contact us and we will provide you customized report.


Table of Contents

    Global Intravenous (IV) Solutions Market Segment Research Report 2022

      1. Research Scope

        2. Market Overview

        • 2.1 Product Introduction, Application, Picture
        • 2.2 Global Intravenous (IV) Solutions Market by Value
          • 2.2.1 Global Intravenous (IV) Solutions Revenue by Type
          • 2.2.2 Global Intravenous (IV) Solutions Market by Value (%)
        • 2.3 Global Intravenous (IV) Solutions Market by Production
          • 2.3.1 Global Intravenous (IV) Solutions Production by Type
          • 2.3.2 Global Intravenous (IV) Solutions Market by Production (%)

        3. The Major Driver of Intravenous (IV) Solutions Industry

        • 3.1 Historical & Forecast Global Intravenous (IV) Solutions Demand
        • 3.2 Largest Application for Intravenous (IV) Solutions (2018-2028)
        • 3.3 The Major Downstream Company in China Market 2022

        4. Global and Regional Intravenous (IV) Solutions Market

        • 4.1 Regional Market Size in Terms of Production & Demand (2022)
        • 4.2 Regional Market Share in Terms of Revenue (2018-2022)
        • 4.3 Concentration Ratio (CR5& CR10) of Intravenous (IV) Solutions Market
        • 4.4 Mergers & Acquisitions, Expansion Plans

        5. US Intravenous (IV) Solutions Production, Demand (2018-2028)

        • 5.1 Current and Estimated Production Breakdown by Type
        • 5.2 Current and Estimated Demand Breakdown by Type
        • 5.3 Current and Estimated Demand Breakdown by Application
        • 5.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 5.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        6. Europe Intravenous (IV) Solutions Production, Demand (2018-2028)

        • 6.1 Current and Estimated Production Breakdown by Type
        • 6.2 Current and Estimated Demand Breakdown by Type
        • 6.3 Current and Estimated Demand Breakdown by Application
        • 6.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 6.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        7. China Intravenous (IV) Solutions Production, Demand (2018-2028)

        • 7.1 Current and Estimated Production Breakdown by Type
        • 7.2 Current and Estimated Demand Breakdown by Type
        • 7.3 Current and Estimated Demand Breakdown by Application
        • 7.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 7.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        8. Japan Intravenous (IV) Solutions Production, Demand (2018-2028)

        • 8.1 Current and Estimated Production Breakdown by Type
        • 8.2 Current and Estimated Demand Breakdown by Type
        • 8.3 Current and Estimated Demand Breakdown by Application
        • 8.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 8.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        9. India Intravenous (IV) Solutions Production, Demand (2018-2028)

        • 9.1 Current and Estimated Production Breakdown by Type
        • 9.2 Current and Estimated Demand Breakdown by Type
        • 9.3 Current and Estimated Demand Breakdown by Application
        • 9.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 9.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        10. Korea Intravenous (IV) Solutions Production, Demand (2018-2028)

        • 10.1 Current and Estimated Production Breakdown by Type
        • 10.2 Current and Estimated Demand Breakdown by Type
        • 10.3 Current and Estimated Demand Breakdown by Application
        • 10.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 10.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        11. Southeast Asia Intravenous (IV) Solutions Production, Demand (2018-2028)

        • 11.1 Current and Estimated Production Breakdown by Type
        • 11.2 Current and Estimated Demand Breakdown by Type
        • 11.3 Current and Estimated Demand Breakdown by Application
        • 11.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 11.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        12. Global Intravenous (IV) Solutions Average Price Trend

        • 12.1 Market Price for Each Type of Intravenous (IV) Solutions in US (2018-2022)
        • 12.2 Market Price for Each Type of Intravenous (IV) Solutions in Europe (2018-2022)
        • 12.3 Market Price for Each Type of Intravenous (IV) Solutions in China (2018-2022)
        • 12.4 Market Price for Each Type of Intravenous (IV) Solutions in Japan (2018-2022)
        • 12.5 Market Price for Each Type of Intravenous (IV) Solutions in India (2018-2022)
        • 12.6 Market Price for Each Type of Intravenous (IV) Solutions in Korea (2018-2022)
        • 12.7 Market Price for Each Type of Intravenous (IV) Solutions in Southeast Asia (2018-2022)

        13. Industrial Chain (Impact of COVID-19)

        • 13.1 Intravenous (IV) Solutions Industrial Chain Analysis
        • 13.2 Downstream
        • 13.3 Impact of COVID-19
        • 13.4 Post-pandemic Era
        • 13.5 Technology Trends of Intravenous (IV) Solutions

        14. Intravenous (IV) Solutions Competitive Landscape

        • 14.1 ICU Medical Inc. (U.S.)
          • 14.1.1 ICU Medical Inc. (U.S.) Company Profiles
          • 14.1.2 ICU Medical Inc. (U.S.) Product Introduction
          • 14.1.3 ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Sales, Revenue (2018-2022)
          • 14.1.4 Strategic initiatives
        • 14.2 B. Braun Melsungen AG (Germany)
          • 14.2.1 B. Braun Melsungen AG (Germany) Company Profiles
          • 14.2.2 B. Braun Melsungen AG (Germany) Product Introduction
          • 14.2.3 B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Sales, Revenue (2018-2022)
          • 14.2.4 Strategic initiatives
        • 14.3 Fresenius Kabi AG (Germany)
          • 14.3.1 Fresenius Kabi AG (Germany) Company Profiles
          • 14.3.2 Fresenius Kabi AG (Germany) Product Introduction
          • 14.3.3 Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Sales, Revenue (2018-2022)
          • 14.3.4 Strategic initiatives
        • 14.4 Baxter (U.S.)
          • 14.4.1 Baxter (U.S.) Company Profiles
          • 14.4.2 Baxter (U.S.) Product Introduction
          • 14.4.3 Baxter (U.S.) Intravenous (IV) Solutions Sales, Revenue (2018-2022)
          • 14.4.4 Strategic initiatives
        • 14.5 Amanta Healthcare (India)
          • 14.5.1 Amanta Healthcare (India) Company Profiles
          • 14.5.2 Amanta Healthcare (India) Product Introduction
          • 14.5.3 Amanta Healthcare (India) Intravenous (IV) Solutions Sales, Revenue (2018-2022)
          • 14.5.4 Strategic initiatives
        • 14.6 Terumo Medical Corporation (Tokyo)
          • 14.6.1 Terumo Medical Corporation (Tokyo) Company Profiles
          • 14.6.2 Terumo Medical Corporation (Tokyo) Product Introduction
          • 14.6.3 Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Sales, Revenue (2018-2022)
          • 14.6.4 Strategic initiatives
        • 14.7 Grifols S.A. (Spain)
          • 14.7.1 Grifols S.A. (Spain) Company Profiles
          • 14.7.2 Grifols S.A. (Spain) Product Introduction
          • 14.7.3 Grifols S.A. (Spain) Intravenous (IV) Solutions Sales, Revenue (2018-2022)
          • 14.7.4 Strategic initiatives

        15. Conclusion

          16. Methodology and Data Source

          Summary:
          Get latest Market Research Reports on Intravenous (IV) Solutions. Industry analysis & Market Report on Intravenous (IV) Solutions is a syndicated market report, published as (Post-pandemic Era)-Global Intravenous (IV) Solutions Market Segment Research Report 2022. It is complete Research Study and Industry Analysis of Intravenous (IV) Solutions market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

          Last updated on

          REPORT YOU MIGHT BE INTERESTED

          Purchase this Report

          $2,850.00
          $5,700.00
          2,339.85
          4,679.70
          2,773.05
          5,546.10
          379,848.00
          759,696.00
          225,520.50
          451,041.00
          Credit card Logo

          Related Reports


          Reason to Buy

          Request for Sample of this report